2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity (Q27619603)

2

0 references

Y H Choi

3

0 references

B J Sung

4

0 references

N K Shin

5

0 references

H C Shin

6

0 references

Y C Sung

7

0 references

B H Oh

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

8

0 references

language of work or name

English

0 references

publication date

August 1999

0 references

published in

Immunity

0 references

volume

11

0 references

issue

2

0 references

page(s)

253-61

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Emerging families of cytokines and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Expression, purification and crystallization of recombinant human TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

A family of ligands for the TNF receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

An extensively modified version of MolScript that includes greatly enhanced coloring capabilities

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Classical electrostatics in biology and chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Structure of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Formation of ion-permeable channels by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

2 A crystal structure of an extracellular fragment of human CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

The nerve growth factor/tumor necrosis factor receptor family.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

1 reference

7 January 2021

Structures of the extracellular domain of the type I tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

The role of polar interactions in the molecular recognition of CD40L with its receptor CD40

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Structure-activity studies of human tumour necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980100-4

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference